Health
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk
National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting edge research into genetic/familial high-risk assessment. PLYMOUTH MEETING, Pa., Nov. 7, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network...
2024-11-07 21:37
1559
New Meta-Analysis Strengthens Evidence That Nuts May Lower Cardiovascular Risk
BARCELONA, Spain, Nov. 7, 2024 /PRNewswire/ -- A recent systematic review and meta-analysis funded by the International Nut and Dried Fruit Council (INC) has just been published in the prestigious scientific journalNutrition, Metabolism and Cardiovascular Diseases.[1] The study showed that curren...
2024-11-07 20:40
2072
StartmeupHK Festival 2024 Wraps Up with Remarkable Success
Championing Technology Across Industries and Empowering Global Startups for a Future of Infinite Opportunities HONG KONG, Nov. 7, 2024 /PRNewswire/ -- The StartmeupHK Festival 2024 concluded successfully on 25 October, following an exciting week filled with engaging events, networking opportunit...
2024-11-07 20:35
1900
Ascletis Announces Promising Results from a Phase I Study in Australia for First-in-Class Muscle-Preserving Weight Loss Drug Candidate ASC47 for the Treatment of Obesity
* Data from a Phase I single ascending dose (SAD) study in Australia in subjects with elevated low-density lipoprotein cholesterol (LDL-C) showed that ASC47, via subcutaneous(SQ) injection, demonstrated a half-life of 21 days, supporting once-monthly administration in patients with obesity * ...
2024-11-07 19:30
1550
MGI Tech Partners with the Human Cell Atlas to Further Advance Worldwide Human Cell Mapping Efforts
SHENZHEN, China, Nov. 7, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced a commercial partnership with Human Cell Atlas (HCA) consortium to further accelerate the human cell mapping...
2024-11-07 19:24
1440
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders
Leads Biolabs grants Oblenio Bio an exclusive option to license LBL-051, a first-in-class CD19xBCMAxCD3tri-specific T-cell engager antibody OAKLAND, Calif. and NANJING, China, Nov. 7, 2024 /PRNewswire/ -- Aditum Bio and Leads Biolabs today announced the formation of Oblenio Bio, which is being f...
2024-11-07 16:29
1626
Fosun Attends CIIE for the Seventh Time - Guo Guangchang: Confident that China's High-Level Openness is a Historical Opportunity
HONG KONG, Nov. 7, 2024 /PRNewswire/ -- On November 5, the 7th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center inShanghai. As a seven-time attendee of the CIIE, Fosun showcased the latest achievements in innovation and global operations at its Fosun...
2024-11-07 13:18
1968
Approx. USD 4.0 M Invested in Product Development for NTDs - GHIT's First Investment in the Development of Diagnostics for Trachoma
TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximatelyJPY 578 million ( USD 4.0 million1) in four projects for the development of new diagnostics and drugs for neglected tropical diseases (NTDs) and malaria.2 GH...
2024-11-07 10:00
1474
Cyient DLM Wins Long Term Deal with Honeywell Aerospace Technologies to Provide Aircraft Cooling Technology
HYDERABAD, India, Nov. 7, 2024 /PRNewswire/ -- Cyient DLM, an integrated partner for design-led manufacturing, announced its partnership with Honeywell Aerospace Technologies for the ground-breaking micro vapor cycle system (Micro VCS), aimed to revolutionize aircraft cooling technology. Cyient D...
2024-11-07 00:11
1893
BRACCO TRIPLES PRODUCTION OF ITS INNOVATIVE CONTRAST AGENT FOR ULTRASOUND IN GENEVA, INAUGURATING A SECOND FACILITY
The significant investment increases the production of CEUS microbubbles The imaging platform for ultrasound, the fruit of Bracco's research, assists doctorsall over the world with more accurate diagnostic data, improving patients' quality of life and facilitating personalized treatment plans PL...
2024-11-06 22:42
1435
Singapore President Tharman's Calligraphy Auctioned for S$308,888 on DeeDa to Benefit the Underprivileged
SINGAPORE, Nov. 6, 2024 /PRNewswire/ -- On November 2, the Singapore Red Cross Society celebrated its 75th Anniversary Benefit Gala ("the Gala") at Shangri-La Singapore. Among the charity auction items was a piece of calligraphy by Singaporean President Tharman Shanmugaratnam, titledWorking Toget...
2024-11-06 19:43
5616
Dallah Hospital Al Nakheel Achieves Global Healthcare Accreditation, Reinforcing its Commitment to Excellence in Medical Travel
PALM BEACH GARDENS, Fla., Nov. 6, 2024 /PRNewswire/ -- Dallah Hospital Al Nakheel, a leading healthcare institution located in the heart of Riyadh, Saudi Arabia, is proud to announce its accreditation by Global Healthcare Accreditation (GHA) for Medical Travel Services. This prestigious recogniti...
2024-11-06 19:00
1182
Esaote Group expands production in India
Innovative series of ultrasound systems are now "Made in India" at the new manufacturing site of subsidiary Esaote Asia Pacific Diagnostic Private Limited in Uttar Pradesh NOIDA, India, Nov. 6, 2024 /PRNewswire/ -- Esaote Group, a leading Italian innovator in medical imaging - ultrasound, dedica...
2024-11-06 18:30
1516
CROWN AESTHETICS PROVIDES CAVENDISH CLINICS WITH AWARD-WINNING SKINPEN® PRECISION TO UPGRADE ITS MICRONEEDLING DEVICE OFFERING
LONDON, Nov. 6, 2024 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories company and leading innovator in the dermatologic and aesthetics industry, is proud to announce that Cavendish Clinics, one of theUnited Kingdom's ("UK") premier aesthetic clinic groups, has upgraded their microneedling d...
2024-11-06 17:00
1272
ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the latest results...
2024-11-06 16:09
1428
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that multiple studies o...
2024-11-06 15:56
1611
Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
NANJING, China, Nov. 6, 2024 /PRNewswire/ -- On November 1, Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-034, a humanized bispecific T-cell engaging antibody targeting both GPRC5D and CD3 which is independently developed by Leads Biolabs with glo...
2024-11-06 15:20
1213
Antengene Presents Results from Three Investigational Programs at the 2024 SITC Annual Meeting
SHANGHAI and HONG KONG, Nov. 6, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cance...
2024-11-06 09:08
1413
Antengene to Present Results from Two Late-Stage Studies of Selinexor Signaling Potential Clinical Breakthrough at ASH 2024
SHANGHAI and HONG KONG, Nov. 6, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cance...
2024-11-06 08:30
1437
MedAdvisor Solutions Launches Telehealth Service on MedAdvisor Patient App, Further Enhancing Access to Care
Patients can now book virtual provider consultations within the App MELBOURNE, Australia, Nov. 6, 2024 /PRNewswire/ -- MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, announced today that new Telehealth functionality is now available within the MedAdvisor ...
2024-11-06 06:47
1404
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7120
